一句话Swiss life science market access consulting firm focused on pricing, reimbursement, HTA, health economics and policy for pharmaceuticals and medical devices.
适合谁Pharmaceutical, biotech and medical device companies seeking market access, pricing and reimbursement strategy support.
核心功能Market access consultingPricing and reimbursement strategyValue assessment and value alignmentPayer acceptance and stakeholder value communicationManaged Entry Agreements and innovative pricing schemesHTAhealth economy and policy analysisSupport for pharmaceuticalsmedical devicescell and gene therapyprecision medicine and digital health care
核心功能模块文本显示其核心并非SaaS软件，而是生命科学市场准入咨询，模块包括市场准入、价值评估、价值认知对齐、付款方接受度、创新回报方案、Pricing & Reimbursement、战略定价、Managed Entry Agreements、HTA、Health Economy、Policy Analysis、Payer Marketing、Stakeholder Management、Value Communication、Project Valuation等。
数据安全合规网站条款说明 pharmalevers.com 使用SSL/HTTPS加密；适用瑞士法律与瑞士司法管辖。未披露企业级数据安全、隐私合规认证或客户数据处理机制。
部署方式(云/自托管)未描述软件部署方式；从正文看是咨询公司网站与内容页面，不是云端或自托管SaaS产品。
中国访问未知
适用场景Pricing and reimbursement planningpayer value argumentationlocal value dossier adaptationmanaged entry scheme designP&R policy analysisDRG/code assessmentstakeholder and payer communication for life science products.